NASDAQ:OM

Outset Medical (OM) Stock Price, News & Analysis

$2.53
-0.10 (-3.80%)
(As of 04/30/2024 ET)
Today's Range
$2.51
▌
$2.64
50-Day Range
$1.94
▌
$3.79
52-Week Range
$1.92
▌
$24.13
Volume
544,254 shs
Average Volume
999,521 shs
Market Capitalization
$130.80 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$5.42

Outset Medical MarketRank™ Stock Analysis

Analyst Rating
Hold
2.33 Rating Score
Upside/​Downside
114.1% Upside
$5.42 Price Target
Short Interest
Bearish
16.60% of Shares Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
N/A
Insider Trading
Selling Shares
$69,521 Sold Last Quarter
Proj. Earnings Growth
Growing
From ($2.28) to ($2.23) Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

1.33 out of 5 stars

Medical Sector

728th out of 918 stocks

Electromedical Equipment Industry

14th out of 20 stocks

OM stock logo

About Outset Medical Stock (NASDAQ:OM)

Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also provides Tablo Data Ecosystem, including TabloHub, a customer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

OM Stock Price History

OM Stock News Headlines

He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Outset Medical shares get Buy rating from BTIG
He Is Giving Away Bitcoin
And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.
Why Dialysis Stocks Are up Today
Q4 2023 Outset Medical Inc Earnings Call
Outset Medical Q4 2023 Earnings Preview
OM Mar 2024 4.000 put
Outset Medical Inc (OM)
See More Headlines
Receive OM Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Outset Medical and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
2/21/2024
Today
4/30/2024
Next Earnings (Confirmed)
5/08/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Electromedical equipment
Sub-Industry
N/A
Fax
N/A
Employees
480
Year Founded
N/A

Price Target and Rating

Average Stock Price Target
$5.42
High Stock Price Target
$6.00
Low Stock Price Target
$3.00
Potential Upside/Downside
+114.1%
Consensus Rating
Hold
Rating Score (0-4)
2.33
Research Coverage
6 Analysts

Profitability

Net Income
$-172,800,000.00
Net Margins
-132.54%
Pretax Margin
-132.14%

Debt

Sales & Book Value

Annual Sales
$130.38 million
Book Value
$2.45 per share

Miscellaneous

Free Float
49,892,000
Market Cap
$130.81 million
Optionable
Not Optionable
Beta
1.99
Ten Starter Stocks For Beginners to Buy Now Cover

Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.

Get This Free Report

OM Stock Analysis - Frequently Asked Questions

Should I buy or sell Outset Medical stock right now?

6 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Outset Medical in the last year. There are currently 1 sell rating, 2 hold ratings and 3 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "hold" OM shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in OM, but not buy additional shares or sell existing shares.
View OM analyst ratings
or view top-rated stocks.

What is Outset Medical's stock price target for 2024?

6 equities research analysts have issued 12-month price targets for Outset Medical's stock. Their OM share price targets range from $3.00 to $6.00. On average, they anticipate the company's share price to reach $5.42 in the next year. This suggests a possible upside of 114.1% from the stock's current price.
View analysts price targets for OM
or view top-rated stocks among Wall Street analysts.

How have OM shares performed in 2024?

Outset Medical's stock was trading at $5.41 at the start of the year. Since then, OM stock has decreased by 53.2% and is now trading at $2.53.
View the best growth stocks for 2024 here
.

When is Outset Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Wednesday, May 8th 2024.
View our OM earnings forecast
.

How can I listen to Outset Medical's earnings call?

Outset Medical will be holding an earnings conference call on Wednesday, May 8th at 5:00 PM Eastern. Interested parties can register for or listen to the call using this link.

How were Outset Medical's earnings last quarter?

Outset Medical, Inc. (NASDAQ:OM) posted its earnings results on Wednesday, February, 21st. The company reported ($0.77) EPS for the quarter, missing the consensus estimate of ($0.74) by $0.03. The business earned $30.51 million during the quarter, compared to analysts' expectations of $30.40 million. Outset Medical had a negative trailing twelve-month return on equity of 102.50% and a negative net margin of 132.54%.

What ETFs hold Outset Medical's stock?

ETFs with the largest weight of Outset Medical (NASDAQ:OM) stock in their portfolio include Procure Disaster Recovery Strategy ETF (FIXT).Procure Disaster Recovery Strategy ETF (FEMA).

What guidance has Outset Medical issued on next quarter's earnings?

Outset Medical issued an update on its FY 2024 earnings guidance on Tuesday, February, 27th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $145.0 million-$153.0 million, compared to the consensus revenue estimate of $148.8 million.

When did Outset Medical IPO?

Outset Medical (OM) raised $175 million in an initial public offering (IPO) on Tuesday, September 15th 2020. The company issued 7,600,000 shares at $22.00-$24.00 per share. BofA Securities, Morgan Stanley and Goldman Sachs acted as the underwriters for the IPO and SVB Leerink and Stifel were co-managers.

Who are Outset Medical's major shareholders?

Outset Medical's stock is owned by many different retail and institutional investors. Top institutional shareholders include Assenagon Asset Management S.A. (1.83%), Griffin Asset Management Inc. (0.19%) and Simplex Trading LLC (0.00%). Insiders that own company stock include D Keith Grossman, James F Hinrichs, James F Hinrichs, Jean-Olivier Racine, John L Brottem, John L Brottem, Leslie Trigg, Marc Nash, Martin Vazquez, Nabeel Ahmed, Rebecca Chambers, Stacey L Porter and Steven S Williamson.
View institutional ownership trends
.

How do I buy shares of Outset Medical?

Shares of OM stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:OM) was last updated on 5/1/2024 by MarketBeat.com Staff

From Our Partners